(Q34117796)

31 July 2017

1 reference

title

The role of VEGF and thrombospondins in skin angiogenesis (English)

1 reference

31 July 2017

1 reference

Detmar M

1

1 reference

31 July 2017

1 December 2000

1 reference

Journal of Dermatological Science

31 July 2017

1 reference

31 July 2017

24 Suppl 1

1 reference

31 July 2017

S78-84

1 reference

Mechanisms of angiogenesis and arteriogenesis

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Molecular regulation of angiogenesis in the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Halting angiogenesis suppresses carcinoma cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Vascular Endothelial Growth Factor-C (VEGF-C) and its Receptors KDR and flt-4 are Expressed in AIDS-Associated Kaposi’s Sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

1 reference

7 January 2021

Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2800%2900145-6

7 January 2021

10.1016/S0923-1811(00)00145-6

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11137400